Table 1. Cell models and conditions of their treatment with NP and laser pulses.
Incubation conditions | Laser pulseparameters | |||||||
Mole-cular target | NP | Vector | Cells:target/non-target | NP con-centratio, NP/ml | Incu-bation time | Dura-tion, ps | Wave-length, nm | Fluence, mJ/cm2 |
EGFR | 50 nmNS | Panitu-mumab | HN31/NOM9 | 2.4*1010 | 24 h | 70 | 820 | 30 |
EGFR | 60 nmNSP | Panitu-mumab | HN31/NOM9 | 2.4*1010 | 24 h | 70 | 532 | 60 |
EGFR | 60 nmNSP | C225 | HN31/NOM9 | 2.4*1010 | 24 h | 70 | 532 | 60 |
- | 60 nmNSP | none | HN31/NOM9 | 2.4*1010 | 24 h | 70 | 532 | 60 |
EGFR | 110 nmNS | C225 | C42B/HS5 | 1.2*1011 | 30 min | 500 | 787 | 38 |
MUC1 | 60 nmNSP | 214D4 | HES/HS5 | 2.4*1010 | 1 h | 500 | 532 | 40 |
PSMA | 60 nmNSP | Anti-PSMA | C42B/HS5 | 1.2*1011 | 30 min | 500 | 532 | 60 |
CD3 | 60 nmNSP | OKT3 | CD3+ T-cells/CD3− BMC | 1.2*1011 | 30 min | 70 | 532 | 37 |
CD3 | 60 nmNSP | OKT3 | J32/JRT3-T3.5 | 1.2*1011 | 45 min | 500 | 532 | 63 |
EGFR | 60 nmNSP | C225 | A549/Fibro-blasts | 6*1010 | 30 min | 500 | 532 | 30 |